Discontinued — last reported Q4 '25
MedTech — Litigation expense
Johnson & Johnson MedTech — Litigation expense remained flat by 0.0% to $225.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 200.0%, from $75.00M to $225.00M. Over 3 years (FY 2021 to FY 2025), MedTech — Litigation expense shows an upward trend with a 108.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Lower expenses are preferred as they indicate fewer legal liabilities and lower operational risk.
Detailed definition
This metric captures the legal costs, settlements, and provisions related to lawsuits or regulatory challenges specifica...
Peer comparison
Commonly reported by large healthcare and medical device companies facing product liability or regulatory litigation.
jnj_segment_medtech_litigation_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.00M | $25.00M | $25.00M | $0.00 | $300.00M | $200.00M | $100.00M | $75.00M | $75.00M | $75.00M | $75.00M | $225.00M | $225.00M | $225.00M | $225.00M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | -33.3% | -50.0% | -25.0% | +0.0% | +0.0% | +0.0% | +200.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | >999% | +700.0% | +300.0% | — | — | — | — | +200.0% | +200.0% | +200.0% | +200.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — litigation expense?
- Johnson & Johnson (JNJ) reported medtech — litigation expense of $225.00M in Q4 2025.
- How has Johnson & Johnson's medtech — litigation expense changed year-over-year?
- Johnson & Johnson's medtech — litigation expense increased by 200.0% year-over-year, from $75.00M to $225.00M.
- What is the long-term trend for Johnson & Johnson's medtech — litigation expense?
- Over 3 years (2021 to 2025), Johnson & Johnson's medtech — litigation expense has grown at a 108.0% compound annual growth rate (CAGR), from $100.00M to $900.00M.
- What does medtech — litigation expense mean?
- The costs associated with legal disputes and settlements involving the medical technology business.